A
RGNX icon

AlphaQuest’s Regenxbio RGNX Stock Holding History

AlphaQuest’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,255
Closed -$75.7K – 1627
2025
Q4 		$75.7K Sell
5,255
-37,649
-88% -$469K ﹤0.01% 1838
2025
Q3 		$414K Buy
42,904
+12,828
+43% +$113K 0.03% 923
2025
Q2 		$247K Sell
30,076
-30,233
-50% -$253K 0.02% 1000
2025
Q1 		$431K Buy
60,309
+52,350
+658% +$389K 0.05% 584
2024
Q4 		$61.5K Sell
7,959
-16,113
-67% -$151K 0.01% 1244
2024
Q3 		$253K Sell
24,072
-17,928
-43% -$219K 0.02% 970
2024
Q2 		$491K Buy
42,000
+41,645
+11,731% +$648K 0.07% 455
2024
Q1 		$7.48K Buy
+355
New +$6.32K ﹤0.01% 1087

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaQuest's RGNX Position: Q1 2026 in Review

AlphaQuest sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 5,255 shares — an estimated $75.7K sold.

AlphaQuest first reported a position in RGNX in Q1 2024 and held it in 8 quarters. The position peaked at $491K in Q2 2024. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • AlphaQuest reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 5,255 Regenxbio shares in Q1 2026, an estimated $75.7K.
  • AlphaQuest first reported a position in Regenxbio in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Regenxbio position peaked at $491K in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.